Forward Together:
Silk Road Medical is now a part of Boston Scientific

Silk Road Medical's innovative and minimally invasive transcarotid artery revascularization (TCAR) technologies are designed to reduce the risk of stroke while treating carotid artery disease, a rapidly growing therapy area that impacts nearly half a million new patients annually in the Unites States. As one company, Boston Scientific is excited to bring this therapy to more patients in the US and around the world.